Join the Lymphoma Community at SupportGroups.com

You may have noticed some links at this site for SupportGroups.com, a fast-growing collection of support communities at one site.

The site is owned and operated by the same company that owns and operates lymphomainfo.net. It has been established as the central support group destination for several reputable health-oriented sites in their Deep Health Network, including:

MyAddiction.com
PeanutAllergy.com
CyberRecovery.net
ConceivingConcepts.com
EatingDisordersOnline.com

The groups relevant to this site at SupportGroups.com are support groups dedicated to Hodgkin's Lymphoma and support groups dedicated to non-Hodgkin's lymphoma.

You can build your own profile, throw out questions to an active and supportive community, even start an online lymphoma journal. Keep coming to lymphomainfo.net for its broad database of informative articles, intelligent blogs (*wink*), and other resources, but check out supportgroups.com to find a compassionate ear, or to help someone else who needs one.

More Articles

More Articles

Amazon.com is pleased to have the Lymphoma Information Network in the family of Amazon.com associates. We've agreed to ship items...

The question ought to be what are myelodysplastic syndromes (MDS), since this is a group of similar blood and bone marrow diseases that...

Merkel Cell Carcinoma (MCC) is a very rare and aggressive skin cancer that usually develops when a person is in his or her 70s. It is...

Radiation Therapy Topics

...

At some point, the Seattle biotech company Cell Therapeutics Inc (CTI) should earn an entry in the Guinness Book of World Records for utter and...

Site Beginnings

This site was started as Lymphoma Resource Page(s) in 1994. The site was designed to collect lymphoma...

Three papers appearing in the journal Blood and pointing towards a regulator-suppressor pill could offer hope to blood cancer...

The US Food and Drug Administration (FDA) has granted a third so-called Breakthrough Therapy Designation for the investigational oral...

The US Food and Drug Administration today has approved an expanded use of Imbruvica (ibrutinib) in patients with...

The U.S. Food and Drug Administration has announced that it has granted "Breakthrough Therapy Designation" for the investigational agent...

According to a new study published in the Proceedings of the National Academy of Sciences, a team from the University of California, San...

Pharmacyclics has announced that the company has submitted a New Drug Application (NDA) to the US Food and Drug Administration (FDA) for...

New research suggests that frontline radioimmunotherapy...

Gilead Sciences has announced results of the company's Phase II study of its investigational compound idelalisib, an oral inhibitor of...

Sitemap